CG Oncology
@cgoncology.com
CG Oncology is a late-stage pharmaceutical company that is passionate about developing and delivering bladder-sparing immunotherapies.
CG Oncology's Company Logos
CG Oncology's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#F26522
Flamingo
242, 101, 34
19, 89, 54
0, 58, 86, 5
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#011646
Midnight
1, 22, 70
222, 97, 14
99, 69, 0, 73
About CG Oncology
CG Oncology is an oncolytic immunotherapy company that is dedicated to developing innovative bladder-saving therapeutics for patients with bladder cancer. They aim to improve the quality of life for urologic cancer patients by providing effective and groundbreaking therapies. Their leading product, cretostimogene grenadenorepvec, is a targeted oncolytic immunotherapy agent that has shown remarkable efficacy in bladder cancer treatment.
CG Oncology is actively engaged in clinical programs and has planned studies in the pipeline to further advance their research. They have achieved an impressive complete response rate with cretostimogene in combination with KEYTRUDA® at any time and at 12 months. This demonstrates the potential of their therapies in helping patients combat bladder cancer.
With a commitment to medical advancements, CG Oncology continues to make significant progress in the field of bladder cancer treatment, as demonstrated by their recent press releases. Patients, medical professionals, and potential partners can find more information about CG Oncology's products and services on their website
Company type
Privately Held
Year founded
2010
Company size
11-50 employees
Related Brands
Tags
Oncolytic immunotherapy
Non-muscle invasive bladder cancer
Intravesical therapy
Clinical trial pipeline
